Clinical trial solutions provider Signant Health has joined the Association of Clinical Research Organizations (ACRO), a global coalition of research and technology companies, to add a technology perspective in future clinical trial research.

ACRO is a non-profit organisation acting as a collective voice for the clinical research industry to regulators and policymakers.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

It educates stakeholders in forming policies that bolster effective and safe clinical trial research.

Signant Health is the 13th member to enter into ACRO as an eCOA, eConsent, and clinical trial technology company.

Signant Health CEO Mike Nolte said: “As a technology provider, Signant brings a unique perspective to ACRO, promoting collaboration across the industry to achieve our shared responsibility for advancing patient-centric clinical research.

“Aligned with our strategy and values, ACRO has prioritised conversations around patient safety, privacy, and technology’s impact on clinical trials, and we are excited to join with ACRO and its member companies to support policy and investment that ensure safe and efficient trials for patients everywhere.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

With its entry into ACRO, Signant Health strives to raise its voice and views on patient-centric clinical research and clinical trial technology.

ACRO executive director Doug Peddicord said: “Signant Health’s mission, ensuring the patient remains at the forefront of clinical trial design and execution, while advancing the efficiency of the clinical trial enterprise, is one shared by the member companies of ACRO.

“We are extremely pleased to welcome Signant as our newest member and look forward to working together to move our industry forward.”